| Christopher David Anna, DPM | |
|
1416 Wainbrook Dr, Augusta, GA 30909-6289 | |
| (706) 312-3668 | |
| (706) 312-3670 |
| Full Name | Christopher David Anna |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 21 Years |
| Location | 1416 Wainbrook Dr, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144262148 | NPI | - | NPPES |
| 003126321A | Medicaid | GA | |
| 4129948 | Other | TN | BLUE CROSS OF TENNESSEE |
| 1506787 | Medicaid | TN | |
| DC1001 | Other | TN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | TN0664 (Tennessee) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD001080 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upperline Healthcare Pc | 4385900653 | 117 |
| Augusta Foot And Ankle, Pc | 4981505658 | 4 |
News Archive
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.
› Verified 7 days ago
| Provider Name | Augusta Foot & Ankle, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619185352 PECOS PAC ID: 4981505658 Enrollment ID: O20040115000923 |
News Archive
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.
› Verified 7 days ago
| Provider Name | Upperline Healthcare Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538686498 PECOS PAC ID: 4385900653 Enrollment ID: O20211101002967 |
News Archive
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher David Anna, DPM 1416 Wainbrook Dr, Augusta, GA 30909-6289 Ph: (706) 312-3668 | Christopher David Anna, DPM 1416 Wainbrook Dr, Augusta, GA 30909-6289 Ph: (706) 312-3668 |
News Archive
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.
Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF's Clinician Development Program (CDP).
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.
› Verified 7 days ago
Henry Greene Bryant Iii, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2030 Walton Way, Augusta, GA 30904 Phone: 706-738-1925 Fax: 706-738-0705 | |
Dr. James Austin Denmark, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2260 Wrightsboro Rd, Suite 154, Augusta, GA 30904 Phone: 706-364-0263 | |
Mickey Dwight Stapp, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1416 Wainbrook Dr, Augusta, GA 30909 Phone: 706-312-3668 Fax: 706-312-3670 | |
Augusta Center For Foot And Ankle Surgery Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1515 Laney Walker Blvd, Augusta, GA 30904 Phone: 706-724-9224 Fax: 706-724-4468 | |
Fyne Foot Care Center Podiatrist Medicare: Medicare Enrolled Practice Location: 1710 Central Ave, Augusta, GA 30904 Phone: 706-373-4402 | |
Upperline Healthcare, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1416 Wainbrook Drive, Augusta, GA 30909 Phone: 706-312-3668 |